Back

Impact of novel therapies and drugs on diurnal patterns of hypertension.

25 August 2018 (13:00 - 13:10)
Organised by:
Congress Presentation Part of: Ambulatory blood pressure monitoring (ABPM): a clinical tool for hypertension diagnosis, risk assessment and therapy evaluation Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Kazuomi Kario

Jichi Medical University, Shimotsuke (Japan)

3 More presentations in this session

Presentation thumbnail
Introduction and goals - Ambulatory blood pressure monitoring (ABPM): a clinical tool for hypertension diagnosis, risk assessment and therapy evaluation.
Video
Presentation thumbnail
Blood pressure variability and cardiovascular risk. Focus on diurnal changes .
Professor G. Parati (Milan, IT)
Presentation thumbnail
Summary and audience discussion - Ambulatory blood pressure monitoring (ABPM): a clinical tool for hypertension diagnosis, risk assessment and therapy evaluation.
Video

Access the full session

Session thumbnail
Ambulatory blood pressure monitoring (ABPM): a clinical tool for hypertension diagnosis, risk assessment and therapy evaluation

The Event

Event poster

ESC Congress 2018

25 August 2018 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Nighttime blood pressure reductions after radiofrequency renal denervation through 24 months in patients with uncontrolled hypertension: pooled analysis from the SPYRAL HTN trials
30 August 2024
thumbnail
Congress Presentation
Ramadan and blood pressure: importance of chronotherapy.
15 April 2021
thumbnail
Congress Presentation
Intrarenal hemodynamics, target organ damage and blood pressure variability, the harmonious foresight into the cardiovascular conundrum
29 June 2021
thumbnail
Congress Presentation
Randomized controlled pilot study comparing different digital solutions for the management of hypertensive patients: the HSMonitor-IT study.
5 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources